These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22095644)

  • 121. Advances in structure determination by cryo-EM to unravel membrane-spanning pore formation.
    Scott H; Huang W; Bann JG; Taylor DJ
    Protein Sci; 2018 Sep; 27(9):1544-1556. PubMed ID: 30129169
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Molecular assembly of lethal factor enzyme and pre-pore heptameric protective antigen in early stage of translocation.
    Alisaraie L; Rouiller I
    J Mol Model; 2016 Jan; 22(1):7. PubMed ID: 26659402
    [TBL] [Abstract][Full Text] [Related]  

  • 123. An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.
    Ohanjanian L; Remy KE; Li Y; Cui X; Eichacker PQ
    Expert Opin Investig Drugs; 2015; 24(7):851-65. PubMed ID: 25920540
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Channel-forming bacterial toxins in biosensing and macromolecule delivery.
    Gurnev PA; Nestorovich EM
    Toxins (Basel); 2014 Aug; 6(8):2483-540. PubMed ID: 25153255
    [TBL] [Abstract][Full Text] [Related]  

  • 125. A protective antigen mutation increases the pH threshold of anthrax toxin receptor 2-mediated pore formation.
    Dennis MK; Mogridge J
    Biochemistry; 2014 Apr; 53(13):2166-71. PubMed ID: 24641616
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Designing inhibitors of anthrax toxin.
    Nestorovich EM; Bezrukov SM
    Expert Opin Drug Discov; 2014 Mar; 9(3):299-318. PubMed ID: 24447197
    [TBL] [Abstract][Full Text] [Related]  

  • 127. (19)F nuclear magnetic resonance and crystallographic studies of 5-fluorotryptophan-labeled anthrax protective antigen and effects of the receptor on stability.
    Chadegani F; Lovell S; Mullangi V; Miyagi M; Battaile KP; Bann JG
    Biochemistry; 2014 Feb; 53(4):690-701. PubMed ID: 24387629
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Nanoscopic surfactant behavior of the porin MspA in aqueous media.
    Perera AS; Wang H; Shrestha TB; Troyer DL; Bossmann SH
    Beilstein J Nanotechnol; 2013; 4():278-84. PubMed ID: 23766950
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Anthrax toxin protective antigen integrates poly-γ-D-glutamate and pH signals to sense the optimal environment for channel formation.
    Kintzer AF; Tang II; Schawel AK; Brown MJ; Krantz BA
    Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18378-83. PubMed ID: 23100533
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Comparison of the structural stability and dynamic properties of recombinant anthrax protective antigen and its 2-fluorohistidine-labeled analogue.
    Hu L; Joshi SB; Andra KK; Thakkar SV; Volkin DB; Bann JG; Middaugh CR
    J Pharm Sci; 2012 Nov; 101(11):4118-28. PubMed ID: 22911632
    [TBL] [Abstract][Full Text] [Related]  

  • 131. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
    Mechaly A; Levy H; Epstein E; Rosenfeld R; Marcus H; Ben-Arie E; Shafferman A; Ordentlich A; Mazor O
    J Biol Chem; 2012 Sep; 287(39):32665-73. PubMed ID: 22869370
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Bacillus anthracis edema factor substrate specificity: evidence for new modes of action.
    Göttle M; Dove S; Seifert R
    Toxins (Basel); 2012 Jul; 4(7):505-35. PubMed ID: 22852066
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Ratcheting up protein translocation with anthrax toxin.
    Feld GK; Brown MJ; Krantz BA
    Protein Sci; 2012 May; 21(5):606-24. PubMed ID: 22374876
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Membrane translocation by anthrax toxin.
    Collier RJ
    Mol Aspects Med; 2009 Dec; 30(6):413-22. PubMed ID: 19563824
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Anthrax protective antigen: prepore-to-pore conversion.
    Miller CJ; Elliott JL; Collier RJ
    Biochemistry; 1999 Aug; 38(32):10432-41. PubMed ID: 10441138
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR.
    Rajapaksha M; Eichler JF; Hajduch J; Anderson DE; Kirk KL; Bann JG
    Protein Sci; 2009 Jan; 18(1):17-23. PubMed ID: 19177347
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Anthrax toxin protective antigen--insights into molecular switching from prepore to pore.
    Bann JG
    Protein Sci; 2012 Jan; 21(1):1-12. PubMed ID: 22095644
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Atomic structure of anthrax protective antigen pore elucidates toxin translocation.
    Jiang J; Pentelute BL; Collier RJ; Zhou ZH
    Nature; 2015 May; 521(7553):545-9. PubMed ID: 25778700
    [TBL] [Abstract][Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.